DBV Technologies | DBVT - Выручка от реализации





Продажи Изменить Дата
Acadia Pharmaceuticals USD 307.96M 39.9M 2026-06
Alnylam Pharmaceuticals USD 1.29B 120M 2026-06
Amarin USD 49.22M 451K 2025-12
BioCryst Pharmaceuticals USD 218.25M 188.3M 2026-06
BioMarin Pharmaceutical USD 990M 224M 2026-06
DBV Technologies USD 645K 2.13M 2025-12
Halozyme Therapeutics USD 481M 104M 2026-06
Incyte USD 1.67B 400M 2026-06
Insmed USD 425.49M 119.53M 2026-06
Ionis Pharmaceuticals USD 268M 22M 2026-06
Neurocrine Biosciences USD 959M 148M 2026-06
PTC Therapeutics USD 361M 88M 2026-06
Sarepta Therapeutics USD 401.3M 329.5M 2026-06
Ultragenyx Pharmaceutical USD 214M 78M 2026-06
United Therapeutics USD 783.3M 1.8M 2026-06